Ardelyx, Inc. (Nasdaq: ARDX), a biopharmaceutical company founded with a mission to discover, develop and commercialize innovative, first-in-class medicines that meet significant unmet medical needs, ...
Although troops’ dental readiness has improved some over the last decade, there’s also been a decline in the number of troops ...
Aion 2 developers did a surprise stream weeks before launch, revealing more information about the pay 2 win, monetization, ...
HLA class I alleles, one known and one newly identified, are linked to allopurinol-induced severe cutaneous adverse reactions ...
Q3 2025 Earnings Call November 6, 2025 5:00 PM ESTCompany ParticipantsTryn Stimart - Chief Legal Officer, CCO, ...
McEwen Inc. ( MUX) Q3 2025 Earnings Call November 6, 2025 11:00 AM EST ...
The highest dose of Eli Lilly’s eloralintide led to 20.1% weight loss after 48 weeks in a Phase II trial, exceeding analyst ...
Eli Lilly said on Thursday it will start late-stage trials of its experimental drug next month after it helped patients lose as much as 20.1% of their weight in a mid-stage study, giving the company ...
Section 2 football's playoffs are underway. Semifinals take place this upcoming Friday and Saturday. More: Section 2 football ...
A large-scale screen of tuberculosis proteins has revealed several possible antigens that could be developed as a new vaccine for TB, the world's deadliest infectious disease.
HealthDay News — Two human leukocyte antigen (HLA) class I alleles are independently associated with an increased risk for allopurinol-induced severe cutaneous adverse reactions (SCARs), according to ...
A large-scale screen of tuberculosis proteins has revealed several possible antigens that could be developed as a new vaccine ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback